Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „significantly“
Suchtreffer
Begriffe & Kennungen
Olanzapine Glenmark Europe · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Glenmark · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Teva · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Teva · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlanzapine Viatris (previously Olanzapine Mylan) · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax Disperzi · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenOlazax · 4.5 · Inhibition of CYP1A2 Fluvoxamine, a specific CYP1A2 inhibitor, has been shown to significantly inhibit the met
Eintrag öffnenPaxlovid · 4.3 · Medicinal products that are potent CYP3A inducers where significantly reduced nirmatrelvir/ritonavir plasma co
Eintrag öffnen